etched a 20 per cent rise in its net profit after tax to $34 million in the half year ending December (when compared to the same time last year).
Revenue rose over 9 per cent to $287 million with a strong lift in BioCeuticals (vitamins and supplements), Chinese and Asian market sales.
Meantime its earnings (EBIT) lifted 19 per cent on the prior corresponding period (pcp) to $26 million.
Its half year dividend is 15 per cent higher than the pcp and at $1.50 per share, fully franked.
Shares in Blackmores are trading 14.11 per cent lower at $137.